JP2007501279A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007501279A5 JP2007501279A5 JP2006533257A JP2006533257A JP2007501279A5 JP 2007501279 A5 JP2007501279 A5 JP 2007501279A5 JP 2006533257 A JP2006533257 A JP 2006533257A JP 2006533257 A JP2006533257 A JP 2006533257A JP 2007501279 A5 JP2007501279 A5 JP 2007501279A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutical composition
- group
- composition according
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 C[C@@](C1)C2c3c(*)cc(**)cc3OC(*)(*)C2CCC1*=C Chemical compound C[C@@](C1)C2c3c(*)cc(**)cc3OC(*)(*)C2CCC1*=C 0.000 description 5
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47231603P | 2003-05-20 | 2003-05-20 | |
| PCT/US2004/015885 WO2004113320A1 (en) | 2003-05-20 | 2004-05-20 | Cannabinoid derivatives, methods of making, and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007501279A JP2007501279A (ja) | 2007-01-25 |
| JP2007501279A5 true JP2007501279A5 (enExample) | 2007-08-30 |
Family
ID=33539041
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006533257A Pending JP2007501279A (ja) | 2003-05-20 | 2004-05-20 | カンナビノイド誘導体、その製造方法、および使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7169942B2 (enExample) |
| EP (1) | EP1633733B1 (enExample) |
| JP (1) | JP2007501279A (enExample) |
| CN (1) | CN1809552A (enExample) |
| AT (1) | ATE496901T1 (enExample) |
| AU (1) | AU2004249669B2 (enExample) |
| CA (1) | CA2526103A1 (enExample) |
| DE (1) | DE602004031221D1 (enExample) |
| DK (1) | DK1633733T3 (enExample) |
| WO (1) | WO2004113320A1 (enExample) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005093052A1 (en) * | 2004-03-26 | 2005-10-06 | Fuji Photo Film Co., Ltd. | Method for selectively separating and purifying rna and method for separating and purifying nucleic acid |
| USRE46558E1 (en) | 2005-04-28 | 2017-09-26 | Paloma Pharmaceuticals, Inc. | Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis |
| US20060257337A1 (en) * | 2005-04-28 | 2006-11-16 | David Sherris | Compositions and methods to treat skin diseases characterized by cellular proliferation and angiogenesis |
| CN101316832A (zh) | 2005-09-29 | 2008-12-03 | Amr科技公司 | δ-9-四氢大麻酚的生成方法 |
| DE102005062098A1 (de) * | 2005-12-22 | 2007-06-28 | Merck Patent Gmbh | Oxaphenanthren-Derivate |
| AU2007219981B2 (en) * | 2006-02-28 | 2013-11-07 | Paloma Pharmaceuticals, Inc. | Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis |
| EP2131655B1 (en) | 2007-03-02 | 2014-05-07 | The University of Tennessee Research Foundation | Tri-aryl/heteroaromatic cannabinoids and use thereof |
| CA2719853A1 (en) * | 2008-03-25 | 2009-10-01 | Paloma Pharmaceuticals, Inc. | Methods of treating fibrotic disorders |
| US8349876B2 (en) | 2008-05-19 | 2013-01-08 | The University Of Tennesee Research Foundation | Pyridine non-classical cannabinoid compounds and related methods of use |
| CA2724737A1 (en) * | 2008-05-19 | 2009-11-26 | The University Of Tennessee Research Foundation | Pyrimidine non-classical cannabinoid compounds and related methods of use |
| US8476439B2 (en) | 2008-05-19 | 2013-07-02 | The University Of Tennessee Research Foundation | Pyridine classical cannabinoid compounds and related methods of use |
| EP2299819A4 (en) * | 2008-05-19 | 2011-07-20 | Univ Tennessee Res Foundation | NONCLASSICAL PYRIDINE CANNABINOID COMPOUNDS AND ASSOCIATED METHODS FOR THEIR USE |
| US8389534B2 (en) * | 2008-05-19 | 2013-03-05 | The University Of Tennessee Research Foundation | Pyrimidine non-classical cannabinoid compounds and related methods of use |
| JP2011520972A (ja) * | 2008-05-19 | 2011-07-21 | ユニヴァーシティ オブ テネシー リサーチ ファウンデーション，ザ | ピリジンの古典的カンナビノイド化合物及び関連する使用方法 |
| JP2011520974A (ja) * | 2008-05-19 | 2011-07-21 | ユニヴァーシティ オブ テネシー リサーチ ファウンデーション，ザ | ピリミジンの古典的カンナビノイド化合物及び関連する使用方法 |
| US9623000B2 (en) | 2008-07-31 | 2017-04-18 | Dekel Pharmaceuticals Ltd | Compositions and methods for treating inflammatory disorders |
| WO2012112791A1 (en) | 2011-02-16 | 2012-08-23 | Paloma Pharmaceuticals, Inc. | Radiation countermeasure agents |
| CN103110582A (zh) * | 2013-03-04 | 2013-05-22 | 上海医药工业研究院 | 大麻酚类化合物微乳剂及其制备方法 |
| EP3160445B1 (en) | 2014-06-26 | 2021-10-20 | Island Breeze Systems Ca, LLC | Mdi related products and methods of use |
| US20170008869A1 (en) * | 2015-07-10 | 2017-01-12 | Noramco, Inc. | Process for the production of cannabidiol and delta-9-tetrahydrocannabinol |
| IL248149B (en) * | 2016-09-29 | 2020-03-31 | Garti Nissim | Formulations of dilutable cannabinoids and processes for their preparation |
| US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
| US20180169061A1 (en) * | 2016-12-15 | 2018-06-21 | Ascent Pharmaceuticals, Inc. | Non-aqueous delta9-tetrahydrocannabinol oral liquid formulations |
| US11786463B2 (en) | 2017-08-27 | 2023-10-17 | Rhodes Technologies | Pharmaceutical compositions for the treatment of ophthalmic conditions |
| EP3745884A1 (en) | 2018-01-31 | 2020-12-09 | Canopy Holdings, Llc | Hemp powder |
| AU2019325479B2 (en) * | 2018-08-20 | 2025-07-31 | Bessor Pharma, Llc | Novel cannabinoids and cannabinoid acids and their derivatives |
| US11040932B2 (en) | 2018-10-10 | 2021-06-22 | Treehouse Biotech, Inc. | Synthesis of cannabigerol |
| CN110269839A (zh) * | 2019-06-15 | 2019-09-24 | 云南飞久逍科技有限公司 | 一种大麻二酚cbd及其纳米乳在荨麻疹或/和鼻炎制剂中的应用 |
| CN119632928A (zh) * | 2019-10-03 | 2025-03-18 | 耶路撒冷希伯来大学伊森姆研究发展有限公司 | 数个脂质体大麻素及其用途 |
| IL292775A (en) | 2019-11-08 | 2022-07-01 | Vella Bioscience Inc | preparations containing cannabidiol (cbd) that act peripherally and their use to improve female sexual function or to treat female sexual disorders |
| US12029718B2 (en) | 2021-11-09 | 2024-07-09 | Cct Sciences, Llc | Process for production of essentially pure delta-9-tetrahydrocannabinol |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3941782A (en) | 1972-04-27 | 1976-03-02 | Sharps Associates | Heterocyclic esters of benzopyrans |
| US3915996A (en) | 1972-10-16 | 1975-10-28 | Abbott Lab | Process for making benzopyrans |
| US3901926A (en) * | 1973-04-02 | 1975-08-26 | Abbott Lab | Alkylphenyl benzopyrans |
| DE4100441A1 (de) * | 1991-01-09 | 1992-07-16 | Mack Chem Pharm | Verfahren zur herstellung von 6,12-dihydro-6-hydroxy-cannabidiol und dessen verwendung zur herstellung von trans-delta-9-tetrahydrocannabinol |
| US5596106A (en) | 1994-07-15 | 1997-01-21 | Eli Lilly And Company | Cannabinoid receptor antagonists |
| US6100259A (en) | 1997-01-21 | 2000-08-08 | Smithkline Beecham Corporation | Cannabinoid receptor modulators |
| FR2758723B1 (fr) | 1997-01-28 | 1999-04-23 | Sanofi Sa | Utilisation des antagonistes des recepteurs aux cannabinoides centraux pour la preparation de medicaments |
| DE19706903A1 (de) | 1997-02-21 | 1998-08-27 | Bayer Ag | Verwendung von bekannten Agonisten des zentralen Cannabinoid-Rezeptors CB 1 |
| CA2283797A1 (en) | 1997-03-18 | 1998-09-24 | Paul Elliot Bender | Novel cannabinoid receptor agonists |
| US5939429A (en) | 1997-09-30 | 1999-08-17 | Virginia Commonwealth University | Cardiovascular uses of cannabinoid compounds |
| US20010009965A1 (en) * | 1998-05-04 | 2001-07-26 | Alexandros Makriyannis | Novel analgesic and immunomodulatory cannabinoids |
| US6563009B1 (en) | 1999-07-12 | 2003-05-13 | Virginia Commonwealth University | Vasodilator cannabinoid analogs |
| FR2799124B1 (fr) | 1999-10-01 | 2004-08-13 | Sanofi Synthelabo | Utilisation des antagonistes des recepteurs aux cannabinoides centraux pour la preparation de medicaments |
| IL132661A (en) | 1999-10-31 | 2008-11-26 | Raphael Mechoulam | Agonists specific for peripheral cannabinoid receptors |
| FR2804604B1 (fr) | 2000-02-09 | 2005-05-27 | Sanofi Synthelabo | Utilisation d'un antagoniste des recepteurs aux cannabinoides centraux pour la preparation de medicaments utiles pour faciliter l'arret de la consommation de tabac |
| EP1254115A2 (en) | 2000-02-11 | 2002-11-06 | Bristol-Myers Squibb Company | Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases |
| US20040039048A1 (en) | 2000-02-11 | 2004-02-26 | Manuel Guzman Pastor | Therapy with cannabinoid compounds for the treatment of brain tumors |
| US6448288B1 (en) | 2000-05-17 | 2002-09-10 | University Of Massachusetts | Cannabinoid drugs |
| KR20030008153A (ko) * | 2000-06-22 | 2003-01-24 | 파모스 코포레이션 | 신규 비-향정신성 카나비노이드 |
| US7507767B2 (en) | 2001-02-08 | 2009-03-24 | Schering Corporation | Cannabinoid receptor ligands |
| US7067539B2 (en) | 2001-02-08 | 2006-06-27 | Schering Corporation | Cannabinoid receptor ligands |
| US6509367B1 (en) | 2001-09-22 | 2003-01-21 | Virginia Commonwealth University | Pyrazole cannabinoid agonist and antagonists |
| CN100567266C (zh) | 2001-11-14 | 2009-12-09 | 先灵公司 | 类大麻苷受体配体 |
| DE60319714T2 (de) | 2002-06-19 | 2009-04-02 | Schering Corp. | Agonisten des cannabinoidrezeptors |
| CA2502511A1 (en) | 2002-10-18 | 2004-05-29 | Pfizer Products Inc. | Cannabinoid receptor ligands and uses thereof |
-
2004
- 2004-05-20 AT AT04752828T patent/ATE496901T1/de not_active IP Right Cessation
- 2004-05-20 EP EP04752828A patent/EP1633733B1/en not_active Expired - Lifetime
- 2004-05-20 US US10/850,588 patent/US7169942B2/en not_active Expired - Fee Related
- 2004-05-20 DE DE602004031221T patent/DE602004031221D1/de not_active Expired - Lifetime
- 2004-05-20 DK DK04752828.6T patent/DK1633733T3/da active
- 2004-05-20 CN CNA2004800174008A patent/CN1809552A/zh active Pending
- 2004-05-20 AU AU2004249669A patent/AU2004249669B2/en not_active Ceased
- 2004-05-20 CA CA002526103A patent/CA2526103A1/en not_active Abandoned
- 2004-05-20 JP JP2006533257A patent/JP2007501279A/ja active Pending
- 2004-05-20 WO PCT/US2004/015885 patent/WO2004113320A1/en not_active Ceased
-
2007
- 2007-01-26 US US11/698,665 patent/US20070167514A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007501279A5 (enExample) | ||
| TW536534B (en) | Difluoroprostaglandin derivatives and pharmaceutical composition comprising them | |
| JP2791544B2 (ja) | クロプロステノール及びフルプロステノールの各類似体 | |
| US9388157B2 (en) | Bicyclic compound and use thereof for medical purposes | |
| JP6065052B2 (ja) | テトラヒドロカルボリン誘導体 | |
| WO1998034916A1 (fr) | Derives de 11,15-o-dialkylprostaglandine e, leur procede de production, et medicaments renfermant ceux-ci comme principe actif | |
| AU1976000A (en) | Nonsteroidal antiinflammatories | |
| JPWO1998034916A1 (ja) | １１，１５−ｏ−ジアルキルプロスタグランジンｅ誘導体、それらの製造方法およびそれらを有効成分として含有する薬剤 | |
| AU609139B2 (en) | Anti-inflammatory furanones | |
| KR101561171B1 (ko) | Ｆ-계열 프로스타글란딘의 제조 방법 | |
| US20030083508A1 (en) | Method for the preparation of citalopram | |
| JP2002509543A (ja) | 緑内障の治療のための副作用のないプロスタグランジン誘導体 | |
| JPH01316363A (ja) | ピペラジン誘導体およびその塩 | |
| WO2005079788A1 (ja) | アミノアルコール化合物 | |
| JP2002543114A5 (enExample) | ||
| JPH06507608A (ja) | ベンゾフラン誘導体 | |
| EP2669280B1 (en) | Bicyclic compound and use thereof for medical purposes | |
| JP4834224B2 (ja) | Ｃ１６不飽和ｆｐ−選択的プロスタグランジン類縁体 | |
| JP2000505448A (ja) | カンプトテシン誘導体及び抗腫瘍剤としてのその利用 | |
| WO1998057930A1 (en) | Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives | |
| EP0818439B1 (en) | Imide derivatives | |
| JP2006506381A5 (enExample) | ||
| JPH037275A (ja) | ２，５，６，７―テトラノル―４，８―インタ―ｍ―フェニレンＰＧＩ↓２誘導体 | |
| WO1998001429A1 (en) | Novel benzimidazole derivatives | |
| JPH06505698A (ja) | 新規化合物 |